Profil
Mr. Tom Burnett is Director & President-Medical Isotopes at Nordion (Canada), Inc. and President & Director at LPBP, Inc. He is on the Board of Directors at Nordion (Canada), Inc. and LPBP, Inc. He received his undergraduate degree from the University of Western Ontario, a graduate degree from Queen's University and an MBA from Richard Ivey School of Business.
Aktive Positionen von Tom Burnett
| Unternehmen | Position | Beginn |
|---|---|---|
| NORDION INC | Director/Board Member | 01.01.2006 |
| LPBP INC | Chairman | - |
Ausbildung von Tom Burnett
| Queen's University | Graduate Degree |
| University of Western Ontario | Undergraduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
LPBP, Inc.
 LPBP, Inc. Financial ConglomeratesFinance LPBP, Inc. is a development stage company. It was previously engaged in blood products business and clinical laboratories services. The company was founded on July 11, 1985 and is headquartered in Ottawa, Canada. | Finance |
